| Metric | Value | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 221.45 Cr | 3.3% | 19.6% |
| Total Income | 222.55 Cr | 3.2% | 19.8% |
| Expenditure | 203.23 Cr | 2.9% | 19.0% |
| PBT | 19.32 Cr | 6.0% | 28.6% |
| Net Profit | 16.40 Cr | 11.1% | 20.6% |
| OPM | 11.45% | 0.11pp | 0.72pp |
| NPM | 7.37% | 0.66pp | 0.05pp |
| EPS | 6.90 | 11.1% | 20.6% |
YoY Beat Masks Sequential Profit Slip and Order Book Standstill
NDR Auto's Q1 beat headline expectations on revenue growth, but profit fell 11% quarter-over-quarter and margins compressed 50 basis points. The order book—the company's growth engine—hasn't moved despite active bidding, signalling execution is slowing and Maruti dependency remains a hard ceiling.
The headline beats; the trend doesn't
+19.6%
₹221.5 Cr | beat prior ~15% guidance
-3.3%
Seasonal model transition; sequential softness
+20.6%
₹16.4 Cr | tracking quarter-on-quarter
-11.1%
₹16.4 Cr down from Q4's ₹18.5 Cr (implied)
NDR Auto's Q1 FY-2027 result reads as a headline beat—19.6% revenue growth, 20.6% profit growth—but the quarter-on-quarter deterioration tells the real story. Profit fell 11%, margins compressed 50 basis points to 11.4% despite management claiming 11–12% EBITDA sustainability, and the order book, which should be the company's growth engine, has not budged from ₹650 Cr. That's the tension the call did not resolve.
Margin claim vs. delivered reality
Management reiterated EBITDA margin guidance of 11–12% on the call. The delivered figures: EBITDA margin 11.88%, but operating profit margin (OPM) landed at 11.4%—a 50 basis-point sequential compression from Q4's ~11.9%. The gap between the claimed EBITDA (11.88%) and the reported OPM (11.4%) reflects startup costs from Hayashi JV (₹58 lakh loss Q1) and the ramp of NDR Auto South, which went into commercial production this quarter. When pressed on rising other expenses, management attributed the increase to marketing for new customer acquisition and R&D for prototypes—spend that will continue as the company executes its diversification plan. The margin story is not expansion; it is maintenance under pressure.
Revenue driven by strong order book execution
Supported₹221.5 Cr +19.6% YoY; ₹650 Cr order book intact but unchanged from Q4
EBITDA margins healthy at 11.88% despite supply chain challenges
OverstatedOPM compressed to 11.4% QoQ; EBITDA 11.88% vs OPM reflects startup costs not addressed on call
No customer pricing pressure; cost increases offset by operational efficiencies
SupportedConfirmed in Q&A; no price reductions demanded; margins stable YoY at ~11–12%
Revenue growth now tied to Maruti production; new projects to drive uptick
SupportedManagement conceded topline growth 'largely in line with production growth at Maruti'; expects 'slight uptick' from South/Safety/SBR ramps
What changed on this call
Four critical shifts from the prior quarter's narrative:
Order book growth has stalled. ₹650 Cr unchanged; management is 'bidding for a lot more business' but zero new wins announced. Prior call language suggested order book expansion; now the company is executing to the same base.
Revenue outperformance vs. Maruti has ended. Growth is now 'largely in line with production growth at Maruti.' Signal: new OEM wins are not materializing fast enough; the company is growing with the OEM, not faster than it.
JV losses will extend several quarters, not clear near-term. Hayashi JV lost ₹58 lakh in Q1; management now says losses will continue until break-even at ₹100–150 Cr revenue. Prior call may have implied faster path to profitability.
New product margins will not expand the company. Management clarified that ambient lighting, SBR, and latch products will have similar or slightly lower returns than seating. The diversification is volume play, not margin lift.
The market's own verdict
The stock fell 2.74% on day 1 post-result, then 4.97% by day 3. The fade—not holding the pop—is the street's assessment that the sequential weakness and stagnant order book outweigh the YoY beat. The stock now trades at ₹802.2, down 23.75% from its all-time high of ₹1,052, and is below both the 20-day and 50-day simple moving averages, though still above the 200-day average. RSI at 48.6 suggests neutral momentum, not distress selling, but the weak post-result action indicates low conviction. Ownership remains heavily concentrated: promoter 73.13%, FII 0.08%, DII 0.01%. There is no institutional buying to support the stock on sequential weakness. The 52-week range of ₹605–₹1,052 shows the stock retraced most of its COVID-era gains; the current price is closer to the lows than the highs, a sign that the market is repricing longer-term execution risk.
The bull-bear ledger
Order book maintained: ₹650 Cr intact and executing through 2030; no material customer loss.
Bharat Seats JV outperforming: 35% YoY growth, exceeded expectations, tracking ₹3,500 Cr by FY30.
Margin guidance delivered: EBITDA 11.88% hit, all commodities indexed, cost control credible.
New capacity on track: NDR South SOP Q2 FY27 (₹70–80 Cr potential), Safety/SBR/Latch ramping early FY28.
Long-term ₹3,000 Cr target maintained: ₹2,000 Cr organic (order book + new facilities) + ₹1,000 Cr inorganic by FY30.
Sequential PAT decline of 11% despite YoY beat: signals Q4 was elevated and Q1 ramp costs are biting.
Margin compression 50 bps QoQ despite EBITDA claim: OPM 11.4% vs 11.9% prior quarter; startup costs will persist.
Order book stagnation despite bidding: ₹650 Cr flat; new OEM wins (Toyota, Kia) unconfirmed; growth ceiling visible.
Maruti dependency unchecked: 19.6% growth now matches Maruti production pace, not faster. Diversification is early-stage.
JV losses to extend several quarters: Hayashi will drag consolidated PAT until ₹100–150 Cr revenue break-even.
Inorganic ₹1,000 Cr component speculative: no M&A pipeline disclosed; FY30 target hinges on unannounced deals.
Toyota Aurangabad delayed to CY2029: capex deferred, but growth curtailed if Toyota India ramp slips further.
Risks, ranked by how much they should concern a holder
Maruti concentration unchecked
HighRevenue growth now matches Maruti production pace; Q1 confirmed this explicitly. Diversification (Toyota, Kia) in early stage with no confirmed wins. A production slowdown at Maruti is a direct revenue slowdown for NDR.
JV losses extending several quarters
MediumHayashi ₹58 lakh loss Q1, to continue until ₹100–150 Cr revenue break-even. NDR South ramp will also incur startup costs. Consolidated PAT will absorb these drains through at least early FY28.
Order book stagnation despite bidding
Medium₹650 Cr flat; no new wins announced despite 'bidding for a lot more business.' If order book doesn't grow by Q3, it signals new OEM wins are not materializing—a structural slowdown in execution.
Margin compression signals persist
MediumOPM down 50 bps QoQ despite EBITDA claim; management shifted from confident reaffirmation to 'should be 11–12%.' Ramp costs (South, new products) will keep pressure on OPM through early FY28.
Inorganic ₹1,000 Cr component unproven
Low to MediumFY30 ₹3,000 Cr target splits ₹2,000 Cr organic (visible) and ₹1,000 Cr inorganic (unannounced). If M&A doesn't materialize, target slips to ~₹2,500 Cr—a 17% miss on long-term guidance.
Toyota Aurangabad delayed to CY2029
LowCapex deferral saves cash near-term, but growth visibility from Toyota curtailed. If plant start slips further, Aurangabad-tied revenue push won't materialize in FY28–29.
The debate
What to watch next quarter
1 · Order book growth (quarterly disclosure)
If ₹650 Cr remains flat by Q2 or Q3, it signals new OEM wins are not materializing and Maruti concentration is structural, not cyclical. Analyst focus will shift to dividend sustainability vs. capex—a negative repricing event.
2 · NDR South ramp revenue (Q2 onwards)
SOP expected Q2 FY27. Early numbers will indicate whether ₹70–80 Cr potential is realistic or conservative. Also watch for startup losses in consolidated P&L; if South incurs ₹2–3 Cr loss in Q2, PAT headwind will extend to Q3.
3 · Hayashi JV losses trajectory and new OEM wins
Q2 Hayashi loss should show whether ₹58 lakh burn is baseline or a seasonal trough. Management said losses continue 'some quarters'—timing matters for consolidated PAT recovery. Also watch for any Toyota Aurangabad business wins; if none by Q2, CY29 plant start will be in jeopardy and capex guidance may slip.
The single number to track
Order book. If ₹650 Cr doesn't move by Q3 FY-2027, the Maruti dependency risk is no longer a caution—it's a fact. At that point, the company is a steady 10–15% growth vehicle tied to OEM production cycles, not a 20%+ compounder. The street's -4.97% fade post-result is justified; it's pricing in that risk now.
NDR Auto is not broken. The company executed operationally—hit order book, delivered margin guidance, grew Bharat Seats, commenced new facilities. But the quarter is a reminder that headlines can mask trends. Sequential profit declined 11%, margins compressed 50 bps, the order book stalled, and management's tone shifted from confident to hedged. Management is credible on operations but evasive on new product revenue and inorganic M&A, the components of the ₹3,000 Cr FY30 target. The risk is not near-term distress; it is that the company is more Maruti-dependent and execution-constrained than the prior call suggested. For a holder, the message is steady execution, not a step-change. For an entry, wait for order book growth confirmation or a margin inflection from the new facilities—neither is visible yet.
Strong YoY growth masks sequential PAT decline; margin compression QoQ
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit prior guidance: ₹650 Cr order book maintained, margins 11–12% achieved. Q1 beat ~15% FY27 growth assumption. But sequential weakness (-11.1% PAT) and order book stagnation despite bidding signal caution.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 beat YoY (+19.6% revenue, +20.6% PAT) but sequential decay (-11.1% PAT, -50 bps margin) signals near-term pressure. Order book ₹650 Cr stable but not growing; new JVs loss-making. Management credible on operations but hedged on growth ('slight uptick' only), and Maruti concentration limits upside. Long-term ₹3,000 Cr target feasible but inorganic ₹1,000 Cr component highly uncertain.
₹221.5 Cr
Revenue · +19.6% YoY₹16.4 Cr
Reported PAT · +20.6% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue driven by strong order book execution
MET₹221.5 Cr, +19.6% YoY; ₹650 Cr order book intact but unchanged from last quarter
EBITDA margins remained healthy at 11.88% despite supply chain challenges
OVERSTATEDOPM 11.4% delivered; compressed from Q4 FY26 ~11.9%; EBITDA 11.88% not directly comparable to OPM
No pricing pressure from customers; cost increases offset by operational efficiencies
METConfirmed in Q&A; no customer price reductions demanded; margins stable YoY at ~11–12%
Revenue growth tied to Maruti production; new projects to drive uptick
METManagement acknowledged growth now matches Maruti pace (was higher before); expects 'slight uptick' from South/Safety/SBR/Latch ramping
NDR South plant revenue potential ₹70–80 Cr; Hayashi JV to break-even at ₹100–150 Cr revenue
METQuantified in call; South SOP Q2 FY27; Hayashi losses to continue several quarters
Earnings quality
What changed since the last call
Order book growth absent
NeutralOrder book ₹650 Cr maintained from last quarter; no new wins announced. Management said 'bidding for a lot more' but no confirmations. Prior expectation of order book growth not materializing.
Revenue growth tied to Maruti production
DowngradeManagement conceded Q1 topline growth 'largely in line with production growth at Maruti.' Prior quarters saw outperformance. Signals slowdown in new OEM wins vs prior trajectory.
JV losses to be multi-quarter, not near-term breakeven
DowngradeHayashi JV: ₹58 lakh loss Q1; management now says losses continue 'some quarters' until break-even at ₹100–150 Cr revenue. Prior call may have signaled faster inflection.
Margin sustainability claim hedged
NeutralManagement stated margins 'should be 11–12%' going forward; delivered 11.4% in Q1. QoQ compression from ~11.9% not acknowledged. Tone shifted to 'commodity indexed; should maintain' vs prior confidence.
New non-seat products to have similar, not higher, margins
DowngradeManagement clarified new products (ambient, SBR, latch) have similar/slightly lower ROCEs than seating. No margin expansion from diversification; only volume upside.
The Q&A
Analysts pressed hard on margin trends, order book growth, and revenue diversification. Management held firm on 11–12% margin sustainability but lacked conviction on new OEM wins. One analyst flagged Maruti concentration risk; management acknowledged but offered no quantified mitigation. Overall tone: measured, defensive on near-term, evasive on new product revenue forecasts.
Order book composition — Tanish Vhora, InvesQ PMS
AnsweredMostly seat frames and covers; new ambient lighting smaller part. Order book can be added to existing revenue to see booked business.
Ambient lighting order details — Jatin Chawla, RTL Investments
AnsweredCouple of new models for Maruti Suzuki; size small; starting 2028.
Order book growth — Jatin Chawla, RTL Investments
PartialOrder book at similar level; bidding for lot more business; will share confirmations quarterly.
Revenue growth slowdown — Jatin Chawla, RTL Investments
AnsweredNew projects starting (South Q2, Safety/SBR/Latch early FY28) should have uptick.
Brezza supply continuity — Jatin Chawla, RTL Investments
AnsweredYes, continue 100% of the model.
Margin trajectory — Saket Kapoor, Kapoor & Company
PartialMarketing expenses for new customers; R&D for prototypes; will continue as we grow aggressively.
Revenue growth outlook — Saket Kapoor, Kapoor & Company
PartialShould have slight uptick going ahead.
Bharat Seats growth sustainability — Manish Gupta, Equinox Investments
AnsweredExceeded expectations; growth seems sustainable as market doing quite well.
FY30 guidance revision — Manish Gupta, Equinox Investments
DodgedBharat Seats target should be ₹3,500 Cr by 2030; NDR component still tracking ₹3,000 Cr.
Cost advantage — Saikiran, Purnartha Investments
AnsweredMost backward-integrated seat player; scale (1M+ seats) helps. Cost advantage from integration.
Capex guidance — Dhananjai Bagrodia, Alchemy Capital
AnsweredApproximately ₹40–50 Cr annually.
OEM diversification timeline — Romil, Electrum PMS
PartialBidding for Toyota and Kia; working with other two OEMs. Should see ramp in 2–3 years.
Non-seat revenue mix — Romil, Electrum PMS
DodgedSeating will be largest part; non-seating smaller given content per vehicle. No numbers to share now.
Hayashi JV losses — Saket Kapoor, Kapoor & Company
AnsweredLosses will continue several quarters until break-even at sales level. Whole team in place; acquiring new business.
Aurangabad plant timing — Jatin Chawla, RTL Investments
AnsweredHave land; still acquiring business from Toyota. Will set up once business acquired. Toyota now saying CY29 plant start.
Hayashi break-even revenue — Jatin Chawla, RTL Investments
AnsweredShould be ₹100–150 Cr to break-even. Hoping Toyota project comes earlier to help, but also delayed.
Hayashi revenue potential — Tanish Vhora, InvesQ PMS
AnsweredTarget ₹200–300 Cr over course of 5–6 years.
FY30 EBITDA margin guidance — Rajesh Agarwal, Moneyore
DodgedOnly given topline guidance; not giving EBITDA margin guidance.
Guidance
FY27 revenue ~15% growth (from prior FY26 calls); Q1 at +19.6% YoY
MediumGrowth tied to Maruti production; new projects (South, Safety/SBR/Latch) should drive 'slight uptick' but not aggressive. FY27 full-year likely ≤15% if Q2–Q4 softer.
₹3,000 Cr revenue by FY30 (maintained)
LowComprises ₹2,000 Cr organic + ₹1,000 Cr inorganic. Organic visible (order book + new facilities); inorganic uncertain. No acquisition pipeline named.
EBITDA margin 11–12% sustainable
HighQ1 delivered 11.88% EBITDA; all commodities indexed. Management confident on cost recovery. New products to have similar margins (no expansion).
No explicit OPM target; delivered 11.4% vs prior 11.9%
MediumQoQ compression not addressed; ramp costs (South/Hayashi startup) likely cause. Expect margin recovery as facilities ramp.
₹150 Cr total capex across all new plants; ₹40–50 Cr annually for next couple of years
HighSouth (₹23 Cr), Hayashi (JV), Aurangabad (pending Toyota orders). Asset turnover expected ~4×.
Risks the call surfaced
Customer concentration
HighMaruti is core OEM; Q1 revenue growth explicitly tied to Maruti production. New OEM wins (Toyota, Kia) in early stage; no timeline confirmed for material ramp.
New venture losses
MediumHayashi JV booked ₹58 lakh loss Q1; will continue 'some quarters' until ₹100–150 Cr revenue break-even. NDR South startup will also incur ramp costs Q2 onwards.
Order book stagnation
MediumOrder book ₹650 Cr unchanged from last quarter despite active bidding for Toyota, Kia, and others. No new wins announced. Suggests competitive wins difficult.
Margin compression signals
MediumOPM 11.4% compressed 50 bps QoQ from ~11.9%; PAT down 11% QoQ. Management hedged on 'should be 11–12%' rather than confident reaffirmation. Ramp costs may persist.
Toyota Aurangabad delay
LowToyota India plant start pushed to CY29 (was earlier). Aurangabad land idle; capex deferred. Management conceded 'difficult to get much business' given delay.
Management
Score 6/10. Clear on operational specifics (order book, margin drivers, facility timelines) but evasive on new product revenue forecasts and inorganic M&A. Transparent on Maruti dependency and JV losses. Track record mixed: Hit Q1 FY27 numbers (₹221.5 Cr, ₹16.4 Cr PAT, 11.88% EBITDA). Order book maintained ₹650 Cr. But sequential PAT down 11% and order book stagnant despite bidding signal execution slowdown.
1 · Q2 FY27
NDR Auto South (Anantapur) SOP; ₹70–80 Cr revenue potential
2 · Early FY28
NDR Safety, SBR, Latch plants ramping; expect revenue uptick
3 · FY28
Ambient lighting order for Maruti (2028 start); small size initially
Long-term ₹3,000 Cr target feasible but inorganic ₹1,000 Cr component highly uncertain.